Professor Marcus Mall is chair of the Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine at Charité-Universitätsmedizin Berlin, Germany. He is a physician-scientist and specialist in pediatric pulmonology and one of the founding directors of the German Center for Lung Research (DZL). His research focusses on cystic fibrosis, which to date remains the most common fatal hereditary lung disease worldwide, where he has made groundbreaking contributions to unraveling the underlying cause of disease and the development of the first highly effective therapy that tackles cystic fibrosis at its root cause.
Breakthrough Conversations with Marcus Mall
Meet our 2022 Breakthrough of the Year in Life Sciences!
The Falling Walls Conversations offer the unique chance to engage in a live conversation with Marcus Mall. The physician-scientist and chair of the Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine at Charité-Universitätsmedizin Berlin is recipient of the Falling Walls Science Breakthrough of the Year 2022 award in the Life Sciences category.
A specialist in paediatric pulmonology and physician-scientist, Mall led the first clinical trial that demonstrated that a combination therapy of three small molecules leads to unprecedented improvement in lung function in patients affected by cystic fibrosis, which to date remains the most common fatal hereditary lung disease worldwide.
Mall has received numerous research awards, including a Heisenberg Professorship for Translational Pediatric Pulmonology awarded by the German Research Foundation.
About the Breakthrough Conversations
Engage in a live conversation with global science leaders at the Falling Walls Science Summit 2022! The Falling Walls Breakthrough Conversations on 8–9 November give you the unique opportunity to meet outstanding scientists, emerging innovators and science entrepreneurs via our livestream.
Funded by the Federal Ministry of Education and Research and in partnership with Springer Nature, the Breakthrough Conversations offer the extraordinary chance to attend a live streamed interview with breakthrough thinkers and to engage with them in real-time online discussions.
How you can get involved
The 25-minute-interviews will be moderated by Springer Nature editors. The livestream will be integrated into a Zoom call. If you have a question to the guest, you can use the ‘raise hand’ feature in Zoom and the moderator will be informed. The moderator will get back to in the course of the interview and you will be able to ask your question to the guest live on air. Please note that in case of many questions from the audience, we may not be able to consider all of them.
More events with Marcus Mall
Filipe studied the influence of the biomechanics of the tumor microenvironment at The Wistar Institute in Philadelphia, and most recently developed composite biomaterials for the delivery of anticancer drugs at NOVA University of Lisbon. Previously, at Queen Mary University of London, where he obtained his PhD in 2015, where he studied how skin cells respond to their microenvironment by using advanced microfabricated biomaterials, and developed micropatterned surfaces for high-content imaging and drug screening. Filipe’s interests span mechanobiology, biomechanics, cellular imaging, tissue engineering, nanotheranostics and cancer therapies. Filipe joined Nature Biomedical Engineering in November 2021 and he is based in Berlin.